Skip to main content
Clinical Trials/IRCT20160306026938N10
IRCT20160306026938N10
Recruiting
Phase 2

Evaluation of the effectiveness of capsule containing dry extract of Trachyspermum ammi and Melissa officinalis in patients with irritable bowel syndrome (a clinical trial in phase 2B)

Tehran University of Medical Sciences0 sites100 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
Tehran University of Medical Sciences
Enrollment
100
Status
Recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Adherence to diagnostic criteria of Irritable Bowel Syndrome (IBS) including recurrent abdominal pain at least three days in a month during past three months and beginning of symptoms at least from six months ago plus at least two conditions of three pain alleviation conditions after defecation, variations in number of defecation times and changes in stool consistency.
  • Age range of 18\-70 years old
  • Signing the informed consent

Exclusion Criteria

  • Being afflicted with any underlying disease
  • Being allergic to Apiaceae family plants
  • Bowel dysfunctions including abnormal colonoscopy observations
  • Lactation period
  • Consumption of medications for improvement of irritable bowel syndrome symptoms

Outcomes

Primary Outcomes

Not specified

Similar Trials